Skip to Content

10x Genomics Inc Ordinary Shares - Class A TXG Stock Quote

| Rating as of

Morningstar‘s Stock Analysis TXG

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics TXG

Company Profile TXG

Business Description

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Contact
6230 Stoneridge Mall Road
Pleasanton, CA, 94588
T +1 925 401-7300
Industry Health Information Services
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Employees 1,239